iPharma: mHealthCoach

mHealthCoach has won so many Health 2.0 Developer Challenges that Aamer’s been asked if that was their main business model. Actually, their real business has been working with pharma companies. Their virtual nurse Flornce and their underlying drug reminder engine have attracted interest from pharma companies and incipient ACOs.

iPharma: Innovations in Adherence

For patients, improving medication adherence can both bolster patients’ health as well as revenues. But pharma can’t help realize this objective on its own: adherence is a multi-stakeholder sport. Many of the innovations for adherence improvement are coming from outside of pharma…and sometimes aim to help payers (employers, insurance companies) or others whose incentives are not aligned with those of pharma companies

Success in Progress Session

The seven companies who were singled out a successes at this panel last year raised more than $140 million in funding over the past 24 months. Want to know who’s next? Check out this year’s panel of Health 2.0 companies who are building tomorrow’s health market leaders, using novel business models.Albert Santelos (CareCloud), Aamer Ghafar (mHealthCoach), and Bart Foster (SoloHealth) will discuss with us their success to date. And what is yet to come. Marco will try to extract the secret formulas that make these companies stand out from the crowd and reveal Health 2.0 Advisors’ Market Monitor product, which helps you put the success of these companies in (data-rich) context.

health 2.0 SF

iPharma: mHealthCoach

mHealthCoach has won so many Health 2.0 Developer Challenges that Aamer’s been asked if that was their main business model. Actually, their real business has been working with pharma companies. Their virtual nurse Flornce and their underlying drug reminder engine have attracted interest from pharma companies and incipient ACOs.

health 2.0 SF

iPharma: Innovations in Adherence

For patients, improving medication adherence can both bolster patients’ health as well as revenues. But pharma can’t help realize this objective on its own: adherence is a multi-stakeholder sport. Many of the innovations for adherence improvement are coming from outside of pharma…and sometimes aim to help payers (employers, insurance companies) or others whose incentives are not aligned with those of pharma companies

success in progress

Success in Progress Session

The seven companies who were singled out a successes at this panel last year raised more than $140 million in funding over the past 24 months. Want to know who’s next? Check out this year’s panel of Health 2.0 companies who are building tomorrow’s health market leaders, using novel business models.Albert Santelos (CareCloud), Aamer Ghafar (mHealthCoach), and Bart Foster (SoloHealth) will discuss with us their success to date. And what is yet to come. Marco will try to extract the secret fo ...